Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0OT3H
|
||||
Drug Name |
UR-11353
|
||||
Synonyms |
138060-13-6; UR-11353
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Unspecified | Investigative | [1] | ||
Structure |
Download2D MOL |
||||
Formula |
C34H59ClN2O5
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Platelet-activating factor receptor | Target Info | Modulator | ||
KEGG Pathway | Calcium signaling pathway | ||||
Neuroactive ligand-receptor interaction | |||||
Staphylococcus aureus infection | |||||
NetPath Pathway | IL5 Signaling Pathway | ||||
Leptin Signaling Pathway | |||||
Reactome | Class A/1 (Rhodopsin-like receptors) | ||||
G alpha (q) signalling events | |||||
Interferon gamma signaling | |||||
WikiPathways | GPCRs, Class A Rhodopsin-like | ||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
Small Ligand GPCRs | |||||
Interferon gamma signaling | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
References | |||||
REF 1 | Effects of PAF-antagonists in mouse ear oedema induced by several inflammatory agents. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.